Correlation of apparent diffusion coefficients measured by diffusion-weighted MR imaging and standardized uptake values from FDG PET/CT in metastatic neck lymph nodes of head and neck squamous cell carcinomas

Clinical Imaging

Volumn 36, Issue 2, 2012, Pages 90-97

  Nakamatsu, Satoru ^a   Matsusue, Eiji ^b   Miyoshi, Hidenao ^a   Kakite, Suguru ^a   Kaminou, Toshio ^a   Ogawa, Toshihide ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Tottori Prefectural Chuou Hospital   (Japan)

Author keywords

Head and neck; Metastatic lymph node; MRI; PET CT; Squamous cell carcinoma

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; FDG PET; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; HEAD AND NECK; LYMPH NODE; METASTATIC LYMPH NODE; MR IMAGING; SQUAMOUS CELL CARCINOMA; STANDARDIZED UPTAKE VALUES;

CYTOLOGY; MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SURFACE DIFFUSION;

BODY FLUIDS;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMAGE ANALYSIS; IMAGING; LYMPH NODE METASTASIS; MALE; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STANDARDIZED UPTAKE VALUE; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84857430591     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2011.05.002     Document Type: Article

References (26)

1. Rege S, Maass A, Chaiken L, Hoh CK, Choi Y, Lufkin R, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994, 73:3047-3058.
2. van den Brekel MW Lymph nodes metastases: CT and MRI. Eur J Radiol 2000, 33:230-238.
3. van den Brekel MW, Stel HV, Castelijns JA, Nauta JJ, van der Waal I, Valk J, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990, 177:379-384.
4. Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ, et al. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998, 207:123-130.
5. Vandecaveye V, Keyzer FD, Poorten VV, Dirix P, Verbeken E, Nuyts S, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009, 251:134-146.
6. Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A, et al. Role of diffusion-weighted MR imaging in cervical adenopathy. Eur Radiol 2006, 16:1468-1477.
7. Sumi M, Sakihama N, Sumi T, Morikawa M, Uetani M, Kabasawa H, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 2003, 24:1627-1634.
8. King AD, Ahuja AT, Yeung DK, Fong DK, Lee YY, Lei KI, et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 2007, 245:806-813.
9. Wang J, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T, et al. Head and neck lesions: characterization with diffusion weighted echo-planar MR imaging. Radology 2001, 220:621-630.
10. Lang P, Wendland MF, Saeed M, Gindele A, Mathur A, Gooding CA, et al. Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging. Radiology 1998, 206:227-235.
11. Bar-Shalom R, Valdivia AY, Blaufox MD PET imaging in oncology. Semin Nucl Med 2000, 30:150-185.
12. Muylle K, Castaigne C, Flamen P 18F-fluoro-2-deoxy-d-glucose positron emission tomographic imaging: recent developments in head and neck cancer. Curr Opin Oncol 2005, 17:249-253.
13. Adams S, Baum RP, Stuckensen T, Bitter K, Hör G Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998, 25:1255-1260.
14. Paulus P, Sambon A, Vivegnis D, Hustinx R, Moreau P, Collignon J, et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998, 108:1578-1583.
15. Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Wieser S, Heinisch M, et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 2001, 28:816-821.
16. Ng SH, Yen TC, Liao CT, Chang JTC, Chan SC, Ko SF, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005, 46:1136-1143.
17. Murakami R, Uozumi H, Hirai T, Nishimura R, Shiraishi S, Ota K, et al. Impact of FDG-PET/CT imaging on nodal staging for head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2007, 68:377-382.
18. Mijnhout GS, Hoekstra OS, van Liegen A, van Diest PJ, Adèr HJ, Lammertsma AA, et al. How morphometric analysis of metastatic load predicts the (un) usefulness of PET scanning: the case of lymph node staging in melanoma. J Clin Pathol 2003, 56:283-286.
19. Stuckensen T, Kovács AF, Adams S, Baum RP Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 2000, 28:319-324.
20. Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, et al. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 2008, 22:177-184.
21. Kau RJ, Alexiou C, Laubenbacher C, Werner M, Schwaiger M, Arnold W, et al. Lymph node detection of head and neck squamous cell carcinoma by positron emission tomography with fluorodeoxyglucose F18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 1999, 125:1322-1328.
22. Reisser C, Haberkorn U, Strauss LG The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors. J Otolaryngol 1993, 22:231-238.
23. Ho KC, Lin G, Wang JJ, Lai CH, Chang CJ, Yen TC Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. Eur J Nucl Med Mol Imaging 2009, 36:200-208.
24. Bos R, van Der Hoeven JJ, van Der Wall E, van der Groep P, van Diest PJ, Comans EF, et al. Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 2002, 20:379-387.
25. Higashi T, Tamaki N, Torizuka T, Nakamoto Y, Sakahara H, Kimura T, et al. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J Nucl Med 1998, 39:1727-1735.
26. Ito K, Kato T, Ohta T, Tadomoto T, Yamada Y, Ikeda M, Nishino M, et al. Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumor size and cellularity. Eur J Nucl Med 1996, 23:1372-1377.